The Research Programme on Biomedical Informatics (GRIB) is a joint research programme of the Hospital del Mar Medical Research Institute (IMIM) and the Department of Experimental and Health Sciences of the Universitat Pompeu Fabra. GRIB brings together a multidisciplinary team of more than seventy scientists, as well as technical and management staff. Ferran Sanz is the Director of GRIB.
The GRIB mission is to develop and apply computational methods and information technologies for a better understanding and prediction of biological phenomena, giving especial emphasis to those related to the human diseases, their prevention, diagnosis and pharmacological treatment.
GRIB has a wide experience in the participation and coordination of research projects funded by the European Commission and other research funding agencies. GRIB has a long tradition of collaboration with the pharmaceutical and biotechnological industry in the framework of R&D projects and also providing services, especially in the development of computational methods for drug discovery. GRIB staff is involved in pre and postgraduate teaching at the UPF and we are coordinators of the Master in Bioinformatics for Health Sciences.
GRIB is the node for Biomedical Informatics of the Spanish Institute of Bioinformatics (INB) and jointly with Farmaindustria, GRIB coordinates the Plataforma Tecnológica Española de Medicamentos Innovadores (PTEMI). GRIB participates also in the Bioinformatics Barcelona (BIB) platform, which aims to promote training, research, and technology transfer in bioinformatics. Ferran Sanz, GRIB’s director, is the co-president of PTEMI and the scientific director of BIB.
We are located at Barcelona Biomedical Research Park (PRBB) where an exceptional cluster of research programmes and groups are working on Computational Biology and Biomedical Informatics. The collaborations within scientists of these groups are frequent and productive, in particular with the Bioinformatics and Genomics program of CRG and with Hospital del Mar research groups.
The research activity of GRIB has originated the development of numerous scientific software and the creation of some spin-off companies: BioCloud, Acellera, Chemotargets and Pharmatools Interactive Services Ltd.